Why you may be gaining weight after stopping Wegovy

Step 1: Understand what is happening in your body after you stop

Semaglutide works by acting on GLP-1 receptors in the brain and gut, slowing gastric emptying and dampening the hunger signals that drive overeating. While you are taking it, those signals are quietened. When you stop, they come back, often quickly and at full force.

The STEP 1 extension study, published in the New England Journal of Medicine, followed participants for a year after they stopped semaglutide 2.4mg. On average, they regained roughly two-thirds of the weight they had lost during the treatment period. Cardiometabolic markers that had improved also largely returned toward baseline. This is not unusual, it reflects the underlying biology of obesity as a chronic condition that GLP-1 medicines manage rather than cure.

Hunger returning faster than expected, renewed cravings for higher-calorie foods, and a drop in energy that makes activity harder are all consistent with what the physiology would predict. If you want to understand the pattern in more detail, what typically happens with weight gain after stopping Wegovy is covered in depth and is a useful starting point before deciding on next steps. The NHS semaglutide medicines page sets out how semaglutide works and what patients should expect after stopping.

Step 2: Work out why you stopped, because the reason shapes the solution

People stop Wegovy for different reasons, and each one points toward a different path forward. Some reach the end of a time-limited NHS course under a specialist service. Others stop because of cost, a break in supply, side effects at a particular dose, or simply because life got complicated, a holiday, a house move, a month where payday didn't stretch to the pen.

If you stopped because of side effects, it is worth knowing that most gastrointestinal symptoms are dose-related and often settle if treatment is restarted at a lower dose and titrated more slowly. If cost was the issue, understanding the full cost picture for Wegovy in the UK (including what a private prescription actually covers) may change the calculation. If supply was the problem, that has largely resolved as of 2025.

If you stopped because you felt you had reached your goal and no longer needed it, the STEP 1 extension data suggest that for most people the medicine was still doing significant work even when weight loss had plateaued. A frank conversation with a prescriber about ongoing need tends to be more useful than a binary on/off decision made alone.

Step 3: Know which routes are open to you now

Restarting Wegovy is one option. If you were tolerating it well, a prescriber can typically restart at a lower dose and work back up; the adjustment period is usually shorter the second time. There is no clinical barrier to restarting after a break, though a new assessment is needed to confirm current health status and any changes to your circumstances.

Switching to tirzepatide (Mounjaro) is another. As a dual GIP and GLP-1 receptor agonist it acts on two pathways rather than one, and comparing how semaglutide and tirzepatide differ in mechanism can help frame that conversation with your prescriber. The SURMOUNT-5 head-to-head trial, published in 2025, found that tirzepatide produced greater average weight reduction than semaglutide 2.4mg over 72 weeks in adults with obesity.

There is also the question of whether any Wegovy-related restrictions on your previous prescription affect restarting, the rules around Wegovy eligibility are worth reviewing if you are unsure where you stand. NICE recommends semaglutide for a maximum of two years within specialist services under TA875, so NHS routes have specific constraints that a private route does not share in the same way.

Step 4: Build a plan rather than waiting to see what happens

Weight regain after stopping a GLP-1 medicine tends to be fastest in the first few months. Acting early (rather than waiting until regain feels significant) gives you more options and usually means a smaller gap to close.

A prescriber-supervised restart through a regulated service means your current weight, health conditions and any changes since you last treated are properly assessed before anything is dispensed. That assessment matters: the right dose, the right medicine and the right timing are clinical decisions, not things to estimate from how you felt last time.

The lifestyle habits built during treatment (higher protein intake, structured meals, regular movement) do slow regain even without medicine, though for most people they are not sufficient on their own in the longer term. What typically happens in the months after stopping Wegovy is covered in more detail if you want the fuller picture. And if weight has been creeping back while you are still technically on treatment, gaining weight on Wegovy during active treatment has different causes worth understanding separately.

If you would like a prescriber to review your situation and discuss what comes next, check your eligibility for treatment through nume, the consultation is free, and a GPhC-registered prescriber reads every submission the same day.